CD8A and melanoma: Similarly, in experimental lung cancer and malignant melanoma murine models, the combination of metformin and anti-PD-1 ICPIs was associated with CD8+ T-cell tumour infiltration, reduction in myeloid-derived suppressive cells, inhibition of tumour growth and improved outcomes [111,112,113,125,126].